The ‘Angelina Jolie effect’
Intended for healthcare professionals
Research focus Previous     Next

The ‘Angelina Jolie effect’

Caroline McGraw Lecturer, Public health, School of Health Sciences, City, University of London

Inherited mutations in the known breast cancer susceptibility genes (BRCA1 and BRCA2) are associated with an increased risk of developing breast and ovarian cancer. In May 2013, Angelina Jolie disclosed she was a carrier of one of these mutations and announced she had undergone a preventive bilateral mastectomy (PBM). Two years later, she announced she had undergone a laparoscopic bilateral salpingo-oophorectomy. This research digest summarises three recent studies evaluating the effect of her disclosure.

Primary Health Care. 28, 1, 14-14. doi: 10.7748/phc.28.1.14.s13

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or